|
Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry – giving
its pharma, biotech, and CRO readership expert insight and
analysis on the sponsor-service provider landscape.
EPC focusses on key trends, concerns, and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis
on building and managing effective collaborations.
Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-2015, in a move that brings added value to both brands.
With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas
now have unrivalled access to a wealth of shared views
and analyses.
We're also on Twitter! Follow us @EPCmagazine
|
